Our Story
Founded in 2022, TIRZEPATIDE CLINIC has been helping patients reach their weight loss goals for over 3 years. Our founder, Dr Rick Shacket, struggled with weight issues himself and wanted to create a program that was both effective and sustainable. Today, we have helped thousands of people transform their lives and achieve their optimal health goals.
Miracle drug
Retatrutide is considered a "miracle" drug because it is a first-in-class "triple-agonist" medication that activates three different hormone receptors simultaneously, producing unprecedented weight loss and metabolic improvements in clinical trials.
How Retatrutide Works
Retatrutide is an effective triple-hormone receptor activator that targets 1) GLP-1 or glucagon-like peptide-1 receptors, 2) GIP or glucose-dependent insulinotropic polypeptide receptors, and 3) glucagon receptors. This triple action helps regulate appetite, enhance satiety, and increase energy expenditure.
Adverse Events
Most side effects are gastrointestinal—including nausea, diarrhea, vomiting, and constipation—which are typically mild-to-moderate and worsen during dose escalation. Rapid weight loss has been reported in some participants, which in rare cases led to complications like kidney stones or bone issues. Dysesthesia, a burning or prickling feeling on the skin, can occur. Temporary increases in heart rate have also been observed due to the glucagon component.
Approval Status
Retatrutide is still in clinical trials; it is not yet U.S. Food and Drug Administration (FDA) approved, and long-term safety data are limited. FDA approval is not expected until late 2027 or 2028. Federal regulators warn that unapproved compounded versions of retatrutide for sale on the internet are unauthorized, unregulated, and potentially unsafe. While early results are impressive, it remains under study, and careful medical supervision will be necessary if and when it becomes available.